KRMDKORU Medical Systems, Inc.

Nasdaq korumedical.com


$ 2.13 $ -0.13 (-5.73 %)    

Friday, 14-Jun-2024 15:59:40 EDT
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 2.14
$ 2.22
$ 0.00 x 0
$ 0.00 x 0
$ 2.10 - $ 2.31
$ 1.98 - $ 4.22
160,320
na
97.82M
$ 0.88
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-01-2024 03-31-2024 10-Q
2 03-13-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 03-08-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-03-2022 06-30-2022 10-Q
9 05-04-2022 03-31-2022 10-Q
10 03-02-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-11-2021 06-30-2021 10-Q
13 05-12-2021 03-31-2021 10-Q
14 03-23-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 03-04-2020 12-31-2019 10-K
19 11-06-2019 09-30-2019 10-Q
20 08-07-2019 06-30-2019 10-Q
21 05-07-2019 03-31-2019 10-Q
22 03-05-2019 12-31-2018 10-K
23 11-09-2018 09-30-2018 10-Q
24 08-06-2018 06-30-2018 10-Q
25 05-07-2018 03-31-2018 10-Q
26 11-03-2017 09-30-2017 10-Q
27 08-04-2017 06-30-2017 10-Q
28 05-05-2017 02-28-2017 10-K
29 01-05-2017 11-30-2016 10-Q
30 10-07-2016 08-31-2016 10-Q
31 06-30-2016 05-31-2016 10-Q
32 05-13-2016 02-29-2016 10-K
33 01-08-2016 11-30-2015 10-Q
34 10-02-2015 08-31-2015 10-Q
35 07-10-2015 05-31-2015 10-Q
36 05-08-2015 02-28-2015 10-K
37 01-14-2015 11-30-2014 10-Q
38 10-15-2014 08-31-2014 10-Q
39 07-15-2014 05-31-2014 10-Q
40 05-29-2014 02-28-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 schott-pharma-and-koru-medical-systems-announce-collaboration-to-advance-large-volume-subcutaneous-infusion

The companies, KORU Medical, manufacturer of the proprietary, large-volume, Freedom Infusion System (the "Freedom System...

 koru-medical-systems-signs-supply-agreement-for-phase-iii-clinical-trial-for-a-novel-enzyme-replacement-therapy-to-treat-a-rare-endocrinological-disease

KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology compan...

 koru-medical-systems-q1-2024-adj-eps-002-beats-004-estimate-sales-8198m-beat-7467m-estimate

KORU Medical Systems (NASDAQ:KRMD) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of ...

 koru-medical-systems-announces-successful-appeal-in-eu-notified-body-review

KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology compan...

 b-riley-securities-reiterates-buy-on-koru-medical-systems-maintains-4-price-target

B. Riley Securities analyst William Woods reiterates KORU Medical Systems (NASDAQ:KRMD) with a Buy and maintains $4 price ta...

 koru-medical-systems-q4-2023-adj-eps-002-beats-004-estimate-sales-7186m-beat-6944m-estimate

KORU Medical Systems (NASDAQ:KRMD) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of ...

 earnings-scheduled-for-march-13-2024

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share...

 koru-medical-systems-announced-a-clinical-supply-agreement-for-a-novel-subcutaneous-immunoglobulin-drug-entering-phase-3-trials

The custom product developed for this clinical trial under a prior agreement was built off the foundation of the KORU Medical F...

 canaccord-genuity-reiterates-buy-on-koru-medical-systems-maintains-3-price-target

Canaccord Genuity analyst Caitlin Cronin reiterates KORU Medical Systems (NASDAQ:KRMD) with a Buy and maintains $3 price tar...

 koru-medical-systems-inc-announces-development-agreement-for-next-generation-subcutaneous-immunoglobulin-infusion-system

KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology compan...

 koru-medical-systems-q3-adj-eps-003-beats-005-estimate-sales-700m-miss-793m-estimate

KORU Medical Systems (NASDAQ:KRMD) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of ...

 earnings-scheduled-for-november-8-2023

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.